07:00 , Jun 10, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) gained $0.24 to $19.79 on Friday after partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) submitted a Type II variation application to EMA to expand the European label of Rienso ferumoxytol to...
01:00 , Jun 5, 2013 |  BC Extra  |  Financial News

Accelerate Diagnostics planning $20M rights offering

In vitro diagnostic company Accelerate Diagnostics Inc. (NASDAQ:AXDX) plans to raise $20 million in a rights offering. The company (formerly Accelr8 Technology Corp.) develops and commercializes products for the identification and antibiotic susceptibility testing of...
08:00 , Dec 17, 2012 |  BC Week In Review  |  Financial News

Accelr8 Technology financial update

Accelr8 will transfer its listing to NASDAQ under the ticker "AXDX" from the NYSE MKT, effective Dec. 26. Accelr8 Technology Corp. (NYSE-M:AXK), Denver, Colo.   Business: Supply/Service, Diagnostic   Date announced: 12/12/12   ...
07:00 , Aug 20, 2012 |  BC Week In Review  |  Company News

Accelr8 Technology management update

Accelr8 Technology Corp. (NYSE-M:AXK), Denver, Colo.   Business: Supply/Service, Diagnostic   Hired: Steve Reichling as CFO, formerly general manager at the Spring Bioscience Corp. subsidiary of Roche   ...
07:00 , Jul 9, 2012 |  BC Week In Review  |  Clinical News

BACcel system diagnostic data

A study in 56 spiked blood culture samples showed that Accelr8's BACcel rapid diagnostic system had 100% sensitivity and 94% specificity for detecting multi-drug resistant clinical isolates of Enterobacteriaceae bacteria. Furthermore, Accelr8 said the results...
07:00 , Jul 2, 2012 |  BC Week In Review  |  Company News

Accelr8 Technology management update

Accelr8 Technology Corp. (NYSE-M:AXK), Denver, Colo.   Business: Supply/Service, Diagnostic   Hired: Lawrence Mehren as president, CEO and a director, formerly head of global business of Roche's Roche Tissue Diagnostics business and Ventana Medical Systems...
07:00 , May 21, 2012 |  BC Week In Review  |  Company News

Accelr8 Technology, Denver Health & Hospital Authority diagnostic, infectious news

Accelr8 and Denver Health received notice that the U.S. Department of Defense's Defense Medical Research and Development Program (DMRDP) awarded the partners $2 million to develop Accelr8's BACcel same-shift rapid diagnostic system to detect wound...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Financial News

Accelr8 Technology proposes private placement

Accelr8 Technology Corp. (NYSE-A:AXK), Denver, Colo.   Business: Supply/Service   Date announced: 4/23/12   Type: Private placement   To be raised: Up to $14.4 million   Shares: 14 million   Price: $1.03   Shares outstanding prior: 11.1 million   Investors: Individual investors   Note:...
07:00 , Apr 30, 2012 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Alimera Sciences Inc. (NASDAQ:ALIM) jumped $0.75 (28%) to $3.44 on Tuesday after the Austrian Agency for Health and Food Safety approved Iluvien to treat chronic diabetic macular edema (DME). For the week, the stock...
00:31 , Apr 24, 2012 |  BC Extra  |  Financial News

Accelr8 to raise $14.4M, names new CEO

Accelr8 Technology Corp. (NYSE-A:AXK) plans to raise $14.4 million through the sale of 14 million shares at $1.03 to an investment group that includes the two co-founders of Crabtree Partners -- Jack Schuler and John...